scispace - formally typeset
Y

Yu Chih Liang

Researcher at Taipei Medical University

Publications -  88
Citations -  4700

Yu Chih Liang is an academic researcher from Taipei Medical University. The author has contributed to research in topics: Kinase & Cell growth. The author has an hindex of 35, co-authored 88 publications receiving 4398 citations. Previous affiliations of Yu Chih Liang include Taipei Medical University Hospital & National Taiwan University.

Papers
More filters
Journal ArticleDOI

Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages.

TL;DR: Results of further studies suggest that suppression of transcriptional activation of COX-2 and iNOS by apigenin might mainly be mediated through inhibition of IkB kinase activity.
Journal ArticleDOI

Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade

TL;DR: Results suggest that tumor promotion can be enhanced by ROS and oxidative mitotic signal transduction, and this enhancement can be suppressed by EGCG or other tea polyphenols.
Journal ArticleDOI

Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-κB in mouse macrophages

TL;DR: The results suggest that carnosol suppresses the NO production and iNOS gene expression by inhibiting NF-kappaB activation, and provide possible mechanisms for its anti-inflammatory and chemopreventive action.
Journal ArticleDOI

Molecular modeling of flavonoids that inhibits xanthine oxidase.

TL;DR: The inhibition of xanthine oxidase activity by various flavonoids was assessed, and from the kinetic analysis suggested that flavonoid bind to the reactive site, and structure-based molecular modeling was performed.
Journal ArticleDOI

Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate

TL;DR: The results suggest that EGCG either exerts its growth‐inhibitory effects through modulation of the activities of several key G1 regulatory proteins such as Cdk2 and Cdk4 or mediates the induction of Cdk inhibitor p21 and p27.